PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20823411-5	2010	MATERIALS AND METHODS: Rapamycin and erlotinib, inhibitors of mTOR and EGFR, respectively, were used to treat RIP-Tag2 transgenic mice bearing advanced multifocal PNET.	Erlotinib Hydrochloride	37-46	regulation of phenobarbitol-inducible P450	Mus musculus	110-113